These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28479012)

  • 1. Whole-brain Irradiation Field Design: A Comparison of Parotid Dose.
    Wu CC; Wuu YR; Jani A; Saraf A; Tai CH; Lapa ME; Andrew JIS; Tiwari A; Saadatmand HJ; Isaacson SR; Cheng SK; Wang TJC
    Med Dosim; 2017 Summer; 42(2):145-149. PubMed ID: 28479012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Risk of Xerostomia After Whole-Brain Radiation Therapy and Association With Parotid Dose.
    Wang K; Pearlstein KA; Moon DH; Mahbooba ZM; Deal AM; Wang Y; Sutton SR; Motley BB; Judy GD; Holmes JA; Sheets NC; Kasibhatla MS; Pacholke HD; Shen CJ; Zagar TM; Marks LB; Chera BS
    JAMA Oncol; 2019 Feb; 5(2):221-228. PubMed ID: 30489607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volumetric-modulated arc therapy (VMAT) for whole brain radiotherapy: not only for hippocampal sparing, but also for reduction of dose to organs at risk.
    Sood S; Pokhrel D; McClinton C; Lominska C; Badkul R; Jiang H; Wang F
    Med Dosim; 2017 Winter; 42(4):375-383. PubMed ID: 28822604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NTCP modeling and dose-volume correlations for acute xerostomia and dry eye after whole brain radiation.
    Mavroidis P; Pearlstein KA; Moon DH; Xu V; Royce TJ; Weiner AA; Shen CJ; Marks LB; Chera BS; Das SK; Wang K
    Radiat Oncol; 2021 Mar; 16(1):56. PubMed ID: 33743773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parotid gland as a risk organ in whole brain radiotherapy.
    Noh OK; Chun M; Nam SS; Jang H; Jo S; Oh YT; Lim JC
    Radiother Oncol; 2011 Feb; 98(2):223-6. PubMed ID: 21300416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An efficient Volumetric Arc Therapy treatment planning approach for hippocampal-avoidance whole-brain radiation therapy (HA-WBRT).
    Shen J; Bender E; Yaparpalvi R; Kuo HC; Basavatia A; Hong L; Bodner W; Garg MK; Kalnicki S; Tomé WA
    Med Dosim; 2015; 40(3):205-9. PubMed ID: 25605507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parotid gland radiation dose-xerostomia relationships based on actual delivered dose for nasopharyngeal carcinoma.
    Lou J; Huang P; Ma C; Zheng Y; Chen J; Liang Y; Li H; Yin Y; Liu D; Yu G; Li D
    J Appl Clin Med Phys; 2018 May; 19(3):251-260. PubMed ID: 29664218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved plan quality with automated radiotherapy planning for whole brain with hippocampus sparing: a comparison to the RTOG 0933 trial.
    Krayenbuehl J; Di Martino M; Guckenberger M; Andratschke N
    Radiat Oncol; 2017 Oct; 12(1):161. PubMed ID: 28969706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in Parotid Dosimetry and Expected Normal Tissue Complication Probabilities in Whole Brain Radiation Plans Covering C1 Versus C2.
    Orton A; Gordon J; Vigh T; Tonkin A; Cannon G
    Cureus; 2017 May; 9(5):e1217. PubMed ID: 28589066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Level II lymph nodes and radiation-induced xerostomia.
    Astreinidou E; Dehnad H; Terhaard CH; Raaijmakers CP
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):124-31. PubMed ID: 14697429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study.
    Wu Q; Manning M; Schmidt-Ullrich R; Mohan R
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):195-205. PubMed ID: 10656393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Experience With Biologically Effective Dose-Comparable Short-Course Whole Brain Radiation Therapy for Metastatic Intracranial Disease.
    McClelland S
    Am J Clin Oncol; 2024 Aug; 47(8):397-398. PubMed ID: 38595077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Parotid Gland is an Underrecognized Organ at Risk for Craniospinal Irradiation.
    King MT; Modlin L; Million L; Donaldson SS; Gibbs IC; Choi CY; Soltys SG
    Technol Cancer Res Treat; 2016 Jun; 15(3):472-9. PubMed ID: 25948323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-brain irradiation with hippocampal sparing and dose escalation on metastases: neurocognitive testing and biological imaging (HIPPORAD) - a phase II prospective randomized multicenter trial (NOA-14, ARO 2015-3, DKTK-ROG).
    Grosu AL; Frings L; Bentsalo I; Oehlke O; Brenner F; Bilger A; Fennell JT; Rothe T; Schneider-Fuchs S; Graf E; Schmoor C; Beck J; Becker G; Bock M; Egger K; Urbach H; Lahmann C; Popp I
    BMC Cancer; 2020 Jun; 20(1):532. PubMed ID: 32513138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetric analysis of the alopecia preventing effect of hippocampus sparing whole brain radiation therapy.
    Mahadevan A; Sampson C; LaRosa S; Floyd SR; Wong ET; Uhlmann EJ; Sengupta S; Kasper EM
    Radiat Oncol; 2015 Nov; 10():245. PubMed ID: 26611656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Whole Brain Radiation Therapy in Adults With Newly Diagnosed Metastatic Brain Tumors.
    Gaspar LE; Prabhu RS; Hdeib A; McCracken DJ; Lasker GF; McDermott MW; Kalkanis SN; Olson JJ
    Neurosurgery; 2019 Mar; 84(3):E159-E162. PubMed ID: 30629211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Presentation of a 3D conformal radiotherapy technique for head-and-neck tumors resulting in substantial protection of the parotid glands].
    Kuhnt T; Janich M; Götz U; Gerlach R; Chiricuta IC; Hänsgen G
    Strahlenther Onkol; 2006 Jun; 182(6):325-30. PubMed ID: 16703287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological implications of whole-brain radiotherapy versus stereotactic radiosurgery of multiple brain metastases.
    Xue J; Kubicek GJ; Grimm J; LaCouture T; Chen Y; Goldman HW; Yorke E
    J Neurosurg; 2014 Dec; 121 Suppl():60-8. PubMed ID: 25434938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy.
    Sanghvi SM; Lischalk JW; Cai L; Collins S; Nair M; Collins B; Unger K
    Radiat Oncol; 2017 Feb; 12(1):43. PubMed ID: 28245881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xerostomia after radiotherapy. What matters--mean total dose or dose to each parotid gland?
    Tribius S; Sommer J; Prosch C; Bajrovic A; Muenscher A; Blessmann M; Kruell A; Petersen C; Todorovic M; Tennstedt P
    Strahlenther Onkol; 2013 Mar; 189(3):216-22. PubMed ID: 23354440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.